Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
5
71%
Ph phase_4
1
14%
Ph not_applicable
1
14%

Phase Distribution

5

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
5(71.4%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (71.4%)
Phase 41 (14.3%)
N/A1 (14.3%)

Trials by Status

completed571%
not_yet_recruiting114%
withdrawn114%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingnot_applicable

Glucophage Plus Myo-Inositol vs Glucophage in Glycemic Control Among Patients With Gestational Diabetes Mellitus

NCT06840613
completedphase_1

Bioequivalence Study for Acarbose/Metformin FDC

NCT04065581
completedphase_1

Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects

NCT03458208
completedphase_1

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

NCT01002807
withdrawnphase_4

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

NCT01510522
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06840613Not Applicable

Glucophage Plus Myo-Inositol vs Glucophage in Glycemic Control Among Patients With Gestational Diabetes Mellitus

Not Yet Recruiting
NCT04065581Phase 1

Bioequivalence Study for Acarbose/Metformin FDC

Completed
NCT03458208Phase 1

Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects

Completed
NCT01002807Phase 1

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Completed
NCT01510522Phase 4

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

Withdrawn
NCT01160042Phase 1

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition

Completed
NCT01160068Phase 1

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition

Completed

All 7 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
7